23-Gene Signature Predicts Risk of Follicular Lymphoma Progression

FL progression risk at 2 years was twice as high in the high-risk vs the low-risk group, and the gene-expression score may help to guide treatment.

Source: CancerNetwork - March 1, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Follicular Lymphoma Hematologic Malignancies News Source Type: news